ZYME - Zymeworks Inc.
IEX Last Trade
12.54
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:14:05 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.46%
PREVIOUS CLOSE
CHG
CHG%
$12.54
0.73
0.05%
Summary score
11%
Profitability
8%
Dept financing
9%
Liquidity
74%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2018 - 30-Jun-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.18%
Return on assets
-10.23%
Return on sales
-1688.41%
Return on invested capital
109.16%
Total debt ratio
26.67%
Debt ratio change over timeo
-1.12%
Current Ratio
5.63%
Quick Ratio
5.63%
Cash Position Ratio
5.34%
Short-term ratios 30-Jun-2021 - 30-Jun-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-23.05%
Return on assets
-14.94%
Return on sales
-1648.97%
Return on invested capital
-351.56%
Total debt ratio
35.93%
Debt ratio change over timeo
-1.15%
Current Ratio
3.95%
Quick Ratio
3.95%
Cash Position Ratio
3.59%
Last quarter ratios 30-Jun-2022
The data are presented for the financials results of the last quarter.
Return on equity
-29.07%
Return on assets
-17.84%
Return on sales
-1209.54%
Return on invested capital
-250.34%
Total debt ratio
39.76%
Debt ratio change over time
-1.16%
Current Ratio
3.28%
Quick Ratio
3.28%
Cash Position Ratio
3.02%
Performance ratios (change over 4 years) 30-Jun-2018 - 30-Jun-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-94.8%
Return on assets
-96.56%
Return on sales
333.61%
Return on invested capital
-215.95%
Total debt ratio
-111.73%
Debt ratio change over time
-1.12%
Current Ratio
-2.87%
Quick Ratio
-2.87%
Cash Position Ratio
-2.77%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ZYME | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.18% | -5.26% | 29.03% | 8.2% |
| Return on assets | -10.23% | 3.1% | 3.72% | 6.13% |
| Return on sales | -1688.41% | 29.5% | 37.95% | 40.14% |
| Return on invested capital | 109.16% | 4.18% | 7.5% | 21.19% |
| Profitability | 25% | 32% | 66% | 62% |
| Total debt ratio | 26.67% | 99.44% | 85.54% | 28.23% |
| Debt ratio change over time | -1.12% | 269.43% | 13.18% | 1.21% |
| Dept financing | 7% | 50% | 23% | 7% |
| Current Ratio | 3.95% | 0.87% | 1.55% | 4.29% |
| Quick Ratio | 3.95% | 0.77% | 1.22% | 3.68% |
| Cash Position Ratio | 3.59% | 0.31% | 0.65% | 1.96% |
| Liquididy | 75% | 13% | 20% | 39% |
| Short-term ratios | ZYME | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -23.05% | 20.79% | 66.71% | 7.59% |
| Return on assets | -14.94% | 3.25% | 3.83% | 6.92% |
| Return on sales | -1648.97% | 33.05% | 37.56% | 48.89% |
| Return on invested capital | -351.56% | 3.69% | 5.96% | 19.2% |
| Profitability | 0% | 41% | 66% | 78% |
| Total debt ratio | 35.93% | 89.69% | 92.69% | 25.42% |
| Debt ratio change over time | -1.15% | 55.67% | 15.07% | 0.65% |
| Dept financing | 10% | 49% | 32% | 7% |
| Current Ratio | 3.95% | 0.87% | 1.55% | 4.29% |
| Quick Ratio | 3.95% | 0.77% | 1.22% | 3.68% |
| Cash Position Ratio | 3.59% | 0.31% | 0.65% | 1.96% |
| Liquididy | 73% | 12% | 21% | 62% |